CPHI Milan 2026
10/2026 – 10/2026
会社概要
- 正式社名: ANFARM HELLAS S.A.
- 登録国: Greece
- 住所: Perikleous 53-57 Gerakas, 15344 Athens, Greece
説明:
A leading EU GMP pharmaceutical manufacturer established in 1967, engaged in the development, production, licensing and global sale of quality generic pharmaceuticals. Main activities include licensing-out and international sales, technology transfer and contract manufacturing, contract development, new product development, lyophilization cycle development and optimization, and regulatory affairs services.
事業活動
完成医薬品(製剤)
製造業者受託製造業者(CMO)薬事コンサルタント
受託・アウトソーシングサービス
サービスプロバイダー受託製造業者(CMO)薬事コンサルタント
包装資材
受託製造業者(CMO)薬事コンサルタント
販売市場
- Melanesia: Papua New Guinea
- Western Asia: United Arab Emirates, Armenia, Azerbaijan, Bahrain, Cyprus, Georgia, Iraq, Israel, Jordan, Kuwait, Lebanon, Oman, Palestine, Qatar, Saudi Arabia, Syria, Turkey, Yemen
- Northern Europe: Denmark, Estonia, Finland, Iceland, Ireland, Latvia, Lithuania, Norway, Sweden, United Kingdom
- Southern Europe: Albania
主要製品/サービス
- 原薬(API): Meropenem Pd.I.S.Inf 500mg/Vial, 1g/Vial & 2g/Vial (EU CTD Available), Moxifloxacin Sol.Inf 400mg/250ml (250ml Bottle) (EU CTD Available)
- 受託・アウトソーシングサービス: Esomeprazole Pd.I.S.Inf 40mg/Vial (EU CTD Available), Azithromycin Pd.Sol.Inf 500mg/Vial (EU CTD Available), Caspofungin Pd.C.So.In 50mg/Vial & 70mg/Vial (EU CTD Available), Clarithromycin Pd.Sol.Inf. 500mg/Vial (EU CTD Available), Daptomycin Pd.I.S.Inf. 350 & 500mg/Vial (EU CTD Available), Isavuconazole Pd.C.So.In 200mg/Vial (under development), Tigecycline Pd.Sol.Inf 50mg/Vial (EU CTD Available), Voriconazole Pd.Sol.Inf 200mg/Vial (EU CTD Available), Omeprazole Pd.Sol.Inf 40mg/vial (EU CTD Available), Omeprazole Ps.Inj.Sol 40mg/vial (EU CTD Available), Pantoprazole Pd.Inj.Sol 40mg/Vial (EU CTD Available), Tenoxicam Ps.Inj.Sol 20mg/Vial (EU CTD Available), Vancomycin Pd.Sol.Inf 500mg/Vial (EU CTD Available) & 1g/vial (EU CT Available: Q3 2021)
- 完成医薬品(製剤): Omeprazole Gr.Cap 20mg & 40mg (EU CTD Available), Amikacin Inj.Sol 500mg/2ml (EU CTD Available) & 1g/4ml (EU CTD Available: Q3 2021), Apixaban F.C. Tabs 2.5mg/tab & 5mg/tab (under development), Brivaracetam Oral Solution 10mg/ml (EU CTD Available: Q4 2022), Brivaracetam Sol. Inf 10mg/ml (5ml Vial) (EU CTD Available: Q3 2022), Butamirate Syr 7.5mg/5ml (200ml Bottle) (EU CTD Available), Ceftaroline Fosamil Pd.C.So.In 600mg/Vial (under development), Ceftriaxone Ps.Inj.Sol 1g/Vial (IM, IV) (EU CTD Available), Cefuroxime Pd.Inj.Sol 750mg/Vial & 1.5g/Vial (EU CTD Available), Clindamycin Solution for Injection 150mg/ml (EU CTD Available: 2022), Digoxin Inj.Sol. 0.25mg/ml (2ml Amp) (EU CTD Available), Ertapenem Pd.C.So.In 1g/Vial (under development), Imipenem + Cilastatin Pd.Sol.Inf (500+500)mg/Vial (EU CTD Available), Lacosamide Oral Solution 10mg/ml (EU CTD Available: Q2 2022), Lacosamide Solution for Infusion 10mg/ml (EU CTD Available: Q2 2021), Levofloxacin Sol.Inf 5mg/ml (100ml Bottle) (EU CTD Available), Linezolid Inj.Sol. 2mg/ml (300ml Plastic Bag) (EU CTD Available), L-Carnitine Oral Solution 1g/10ml Vial (EU CTD Available)
- ATC分類(解剖治療化学分類): Palonosetron Inj.Sol. 250mcg/5ml (Vial) (EU CTD Available), Vildagliptin & Metformin Tabs (50+850 mg), (50+1000 mg) (EU CTD Available: Q3 2021), Fosfomycin Pd.Sol.Inf 40mg/m, Aripiprazole Oral Solution 1mg/ml, Somatostatin Ps.Sol.Inf. 3mg/Vial (EU CTD Available)
- 先発品原薬: Ceftazidime/ Avibactam Pd.C.S.Inf (2+0.5)g/vial
当社の製品・サービス
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · ATC (Anatomical Therapeutic Chemical) Classification
証明
評価
(0)
(0)
(0)
(0)
(0)
コメント
フィルター:
並べ替え:
コメントはありません。
評価とコメントを残す